Full-Life Technologies raises $150M; Quince's reboot with pulmonary drug

May 19, 2026 10:38 AM EDT News Briefing Full-Life Tech­nolo­gies rais­es $150M; Quince's re­boot with pul­monary drug ENDPOINTS Plus, news about Ac­cro Bio­science, Hansa Bio­phar­ma, Shang­hai Best-Link Bio­science and UCB. Full-Life Tech­nolo­gies gets $150M: The ra­dio­ther­a­py com­pa­ny has raised … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER